We are live on
!
Find out more
CF
Cantor Fitzgerald Portfolio holdings
AUM
$6.78B
1-Year Est. Return
29.01%
This Fund
S&P 500
This Quarter
Est. Return
-2.34%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.74B
AUM Growth
-$634M
(-15%)
Cap. Flow
-$429M
Cap. Flow
% of AUM
-11.48%
Top 10 Holdings %
Top 10 Hldgs %
17.63%
Holding
694
New
120
Increased
84
Reduced
195
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCMA
HCM Acquisition Corp Class A Ordinary Shares
HCMA
|
+$27.1M |
| 2 |
Domino's
DPZ
|
+$21.4M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$21.1M |
| 4 |
TJX Companies
TJX
|
+$20.9M |
| 5 |
Medpace
MEDP
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NFYS
Enphys Acquisition Corp.
NFYS
|
+$29.4M |
| 2 |
HCVI
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
|
+$26.1M |
| 3 |
TRTL
TortoiseEcofin Acquisition Corp. III
TRTL
|
+$26M |
| 4 |
EOCW
Elliott Opportunity II Corp.
EOCW
|
+$25.9M |
| 5 |
CNDA
Concord Acquisition Corp II
CNDA
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.56% |
| 4 | Consumer Discretionary | 8.41% |
| 5 | Industrials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
ePlus
PLUS
$2.38B
| $336K | 0.01% |
+5,289
| New | +$327K |
|
377
Worthington Enterprises
WOR
$2.74B
| $335K | 0.01% |
8,783
| – | – |
|
378
Collegium Pharmaceutical
COLL
$1.17B
| $335K | 0.01% |
14,971
+3,477
| +30% | +$79.3K |
|
379
Patrick Industries
PATK
$2.79B
| $333K | 0.01% |
6,657
| – | – |
|
380
Jazz Pharmaceuticals
JAZZ
$16.2B
| $331K | 0.01% |
+2,560
| New | +$341K |
|
381
Addus HomeCare
ADUS
$2.18B
| $331K | 0.01% |
+3,889
| New | +$347K |
|
382
Corcept Therapeutics
CORT
$12.7B
| $330K | 0.01% |
12,112
| – | – |
|
383
Evertec
EVTC
$1.95B
| $329K | 0.01% |
8,854
| – | – |
|
|
SWAV
384
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $327K | 0.01% |
1,642
| – | – |
|
385
AbbVie
ABBV
$455B
| $325K | 0.01% |
+2,180
| New | +$320K |
|
386
Agilent Technologies
A
$39.2B
| $325K | 0.01% |
2,903
-75,854
| -96% | -$9.09M |
|
|
TE
387
CALL
T1 Energy
TE
$1.19B
| $319K | 0.01% |
+7,502
| New | +$53.9K |
|
388
Applovin
APP
$136B
| $317K | 0.01% |
7,925
-6,075
| -43% | -$216K |
|
|
XELA
389
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $317K | 0.01% |
+75,000
| New | +$347K |
|
390
Surgery Partners
SGRY
$2.08B
| $316K | 0.01% |
+10,820
| New | +$389K |
|
391
Diodes
DIOD
$3.77B
| $314K | 0.01% |
3,977
| – | – |
|
392
Box
BOX
$4.31B
| $313K | 0.01% |
12,916
| – | – |
|
|
EMCS
393
Xtrackers MSCI Emerging Markets Select ETF
EMCS
$982M
| $311K | 0.01% |
13,630
-113
| -0.8% | -$2.71K |
|
394
RenaissanceRe
RNR
$13.2B
| $307K | 0.01% |
1,550
-310
| -17% | -$59.6K |
|
395
EnerSys
ENS
$6.74B
| $307K | 0.01% |
3,239
| – | – |
|
|
SMAR
396
DELISTED
Smartsheet Inc.
SMAR
| $306K | 0.01% |
7,570
-1,260
| -14% | -$51.7K |
|
397
NetApp
NTAP
$34.1B
| $304K | 0.01% |
4,000
| – | – |
|
398
GSK
GSK
$104B
| $300K | 0.01% |
8,267
-117,207
| -93% | -$4.16M |
|
|
OTLY
399
Oatly Group
OTLY
$460M
| $293K | 0.01% |
+16,370
| New | +$477K |
|
400
Xtrackers S&P MidCap 400 ESG ETF
MIDE
$3.41M
| $291K | 0.01% |
11,604
-48
| -0.4% | -$1.26K |
|
Similar funds
JCAM
CIMLRA
TAM
PS
SPC
SPS
BHM
CIA
Cantor Fitzgerald's Q3 2023 Portfolio in Review
As of Q3 2023, Cantor Fitzgerald held 694 positions worth $3.74B, down 15% from $4.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cantor Fitzgerald withdrew a net $429M in Q3 2023, closing 139 positions and reducing 195 holdings. Its most notable exit was Enphys Acquisition Corp., an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cantor Fitzgerald opened a new position in HCM Acquisition Corp Class A Ordinary Shares worth $2.5M.
- Cantor Fitzgerald's largest Q3 2023 buy was HCM Acquisition Corp Class A Ordinary Shares: 2,500,000 shares worth $2.5M.
- Cantor Fitzgerald added most to iShares 20+ Year Treasury Bond ETF in Q3 2023, an estimated $21.1M increase.
- Cantor Fitzgerald's biggest Q3 2023 reduction was Merck, cutting an estimated $18.8M.
- Cantor Fitzgerald fully exited Enphys Acquisition Corp. in Q3 2023, selling an estimated $29.4M.
- Cantor Fitzgerald's ten largest holdings make up 18% of its $3.74B portfolio in Q3 2023.
- Cantor Fitzgerald opened 120 new positions and closed 139 in Q3 2023.
- Cantor Fitzgerald's portfolio value fell 15% quarter-over-quarter to $3.74B.
Based on Cantor Fitzgerald's 13F filing for Q3 2023, filed 14 Nov 2023.